ÂÜÀòÂÒÂ×

Seth Gleiman has a diverse work experience spanning over multiple industries and roles. Seth is currently serving as the Vice President of Strategy at Galvanize Therapeutics, Inc. since April 2023. Prior to this, they held the position of Senior Director of Strategy at the same company from February 2020 to April 2023.

Before joining Galvanize Therapeutics, Inc., Seth worked at Medtronic - Interventional Lung Solutions. Seth served as the Sr. Manager of Global Upstream R&D and Portfolio from April 2015 to February 2020. In this role, they were responsible for managing global research and development plans and investment portfolios, as well as identifying and managing external strategic partnerships in the field of lung diseases.

Seth's previous experience includes working at Covidien as the Biomaterials Research and Development Manager from May 2011 to April 2015. Seth also served as the Principal Research Scientist - Biomaterials, where they spearheaded technology and product development programs in biomaterials, inventing a revolutionary electrospinning process.

Additionally, Seth has a background in scientific research, having worked at Los Alamos National Laboratory. Seth held various positions, including Scientist, Research Fellow, Technical Staff Member, and Post Doctoral Staff Member, focusing on polymers, materials engineering, and weapon materials and manufacturing.

Overall, Seth Gleiman's work experience showcases their expertise in strategy and research and development across the biotechnology, medical devices, and materials science fields.

Seth Gleiman completed their Bachelor of Science (BS) degree in Chemical Engineering at the University of Delaware from 1990 to 1994. Seth then pursued further education and obtained their Master of Science (MS) degree in Chemical Engineering from the Colorado School of Mines, where they studied from 1994 to 1997. Seth's educational journey continued at the Colorado School of Mines, where they earned a PhD in Chemical Engineering from 1997 to 1999.